BRIEF published on 07/22/2025 at 07:05, 1 year ago Sartorius Reports Strong Growth in First Half of 2025 Life Sciences Sartorius AG EBITDA Increase First Half 2025 Bioprocess Growth
PRESS RELEASE published on 07/22/2025 at 07:00, 1 year ago Sartorius continues growth course; earnings rise at a significantly overproportionate rate Sartorius AG reports continued growth with significant increase in earnings for the first half of 2025. Group's sales revenue up 6.1%. CEO confirms guidance for the full year 2025 Sales Revenue Growth Earnings Sartorius AG Guidance
BRIEF published on 07/01/2025 at 17:35, 1 year ago Sartorius Finalizes Acquisition of MatTek Acquisition Sartorius Drug Development MatTek Cell Technology
PRESS RELEASE published on 07/01/2025 at 17:30, 1 year ago Sartorius completes acquisition of MatTek Sartorius completes acquisition of MatTek from BICO Group AB, expanding its cell technology portfolio and creating synergies with existing solutions for drug development Acquisition Sartorius Drug Development MatTek Cell Technology
BRIEF published on 05/02/2025 at 09:27, 1 year 2 months ago Sartorius Extends Executive Board Tenure for Alexandra Gatzemeyer Executive Board Sartorius AG Biopharmaceutical Industry Alexandra Gatzemeyer Lab Products
PRESS RELEASE published on 05/02/2025 at 09:22, 1 year 2 months ago Sartorius Supervisory Board extends appointment of board member Alexandra Gatzemeyer Sartorius AG extends Dr. Alexandra Gatzemeyer's Executive Board appointment until 2031, responsible for Lab Products & Services Division Executive Board Sartorius AG Appointment Extension Alexandra Gatzemeyer Lab Products & Services Division
BRIEF published on 04/16/2025 at 07:04, 1 year 3 months ago Sartorius Reports Strong Start in 2025 First Quarter EBITDA Margin Sales Growth Sartorius AG First Quarter 2025 Bioprocess Solutions
PRESS RELEASE published on 04/16/2025 at 06:59, 1 year 3 months ago Strong start to the year: Sartorius achieves significant profitable growth in the first quarter Sartorius AG achieves significant profitable growth in the first quarter of 2025 with a 6.5% increase in group sales revenue and a strong start in consumables business Profitable Growth Sales Revenue Sartorius AG First Quarter Consumables Business
BRIEF published on 04/04/2025 at 18:05, 1 year 3 months ago Sartorius to Acquire MatTek from BICO AB Drug Development Regulatory Approval Mergers & Acquisitions 3D Microtissue Models Cell Culture
PRESS RELEASE published on 04/04/2025 at 18:00, 1 year 3 months ago Sartorius to acquire microtissue business MatTek from Swedish BICO AB Sartorius to acquire microtissue business MatTek from Swedish BICO AB, advancing cell culture portfolio with 3D models and primary cells for drug development. Acquisition expands Lab Products & Services division Acquisition Sartorius Microtissue MatTek BICO AB
Published on 07/24/2026 at 23:00, 1 day 2 hours ago NV Gold Announces Closing of Non-Brokered Private Placement
Published on 07/24/2026 at 22:15, 1 day 3 hours ago Gold Terra Announces Closing of First Tranche of C$10.8M LIFE Offering With Strong Participation From Strategic Shareholder David Harquail
Published on 07/24/2026 at 22:05, 1 day 3 hours ago Findev Inc. Announces CCAA Proceedings Involving 1682 Victoria Park Avenue Inc. and Related Party Subordination Arrangement
Published on 07/24/2026 at 20:00, 1 day 5 hours ago Unusual Machines to Announce Second Quarter 2026 Financial Results and Provide Corporate Update
Published on 07/24/2026 at 18:44, 1 day 6 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 07/24/2026 at 17:50, 1 day 7 hours ago Fuller, Smith & Turner PLC: Director / PDMR Shareholding
Published on 07/24/2026 at 17:40, 1 day 7 hours ago 2CRSi SA: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital as of May 31, 2026.
Published on 07/24/2026 at 18:50, 1 day 6 hours ago Disclosure of transactions in own shares from July 20 to July 24, 2026
Published on 07/24/2026 at 08:00, 1 day 17 hours ago Accor signs a definitive binding agreement on the sale of its stake in Essendi
